Pages

.

Showing posts with label Blood. Show all posts
Showing posts with label Blood. Show all posts

Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019

DUBLIN, Feb. 24, 2014
/PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/j8sfj8/blood_pressure

) has announced the addition of the

"Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The rise in prevalence of high/low blood pressure is attributed to a geriatric population, sedentary lifestyle, lack of physical activity and rising stress. It is estimated that people above the age of 55 years have 90% risk of developing high blood pressure. The global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 3,661.3 million by 2019. Social, behavioral and metabolic factors determine and contribute to hypertension. Behavioral risk factors such as physical inactivity, unhealthy diet, consumption of alcohol and tobacco, increase the risk of hypertension.

Manufacturers are coming up with new and innovative digital blood pressure monitoring devices that are easy to use and provide accurate readings instantly. The digital sphygmomanometers market is expected to grow at a faster rate compared to other types of sphygmomanometers (mercury and aneroid) as they are easy to use and provide accurate results. The trend of regular monitoring is fast catching up, with patients opting for automated self-care, thus making use of personal monitoring devices. Currently, majority of the automated blood pressure monitoring devices available are based on the oscillometric method that gives accurate results, along with ease of use.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

4 Blood Pressure Monitoring Testing Market, By Segments

5 Blood Pressure Monitoring Testing Market, By Geography

6 Blood Pressure Monitoring Testing Market, By End Users

7 Competitive Landscape

8 Recommendations

9 Company Profiles

Companies Mentioned:

A&D Medical, Inc CONTEC MEDICAL SYSTEMS CO, LTD Covidien PLC GE Healthcare Masimo Corporation Nihon Kohden Corporation Omron Healthcare, Inc Philips Healthcare Shenzhen Mindray Bio-Medical Electronics Co, Ltd Spacelabs Healthcare Suntech Medical, Inc Welch Allyn For more information visit http://www.researchandmarkets.com/research/j8sfj8/blood_pressure

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more... Résuméabuiyad

HealthMed Holdings Announces New Blood Test That Identifies Individuals Who Are At Risk Of A Heart Attack

HealthMed is Enabling Prevention of Heart Disease By Early Detection. (PRNewsFoto/HealthMed Holdings)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";DOHA, Qatar and IRVINE, Calif., Feb. 13, 2014 /PRNewswire/ -- HealthMed Holdings, a company dedicated to the prevention of cardiovascular disease through innovative laboratory tests in conjunction with preventive strategies, announced today that it has completed validation on a novel blood test that aims to identify individuals who are at risk of a heart attack that might be missed by conventional tests. These individuals have no symptoms and frequently have normal standard blood cholesterol profiles, but are at significant risk of having a heart attack in the near term. The group is actively commercializing the test.

The new MAP Test (Myocardial Assessment Profile) covers pathways involved in unstable cardiac lesions due to inflammation. Inflammation is the most common cause of heart attacks (up to 75%).

HealthMed Holdings Managing Partner, Douglas S. Harrington, MD, said that the test will be offered globally with a focus on nations where there has been a steep rise in cardiac disease, obesity and diabetes.

"Increasing awareness that lifestyle choices significantly determine heart attack and stroke risk, and deficiencies in current diagnostic tools miss, many individuals who go on to have a heart attack or stroke determined a need for ways to identify these individuals so preventive measures can be taken. The health care authorities in many countries are taking a proactive approach to reversing these trends," said Dr. Harrington.

About the MAP Test™
The MAP Test measures compounds in the blood associated with vascular inflammation causing unstable cardiac lesions. Measurement of these compounds in a person's serum enables identification of patients at risk of a heart attack in the near term.  The MAP Test allows physicians to more effectively manage and treat their patients to the new ACC/AHA Cardiac guidelines – aiding in the reduction and prevention of cardiac events. Used in conjunction with other clinical information, the MAP Test's easy to understand results yield better compliance and behavioral changes by patients.

About HealthMed Holdings
HealthMed Holdings is dedicated to promoting preventive healthcare strategies through global alliances to deploy innovative diagnostic technologies in conjunction with lifestyle modification programs and medical compliance education.

Company Contacts:
Douglas S. Harrington, M.D.
Managing Partner, HealthMed Holdings
Al Jabor Group Building, C Ring Road, P.O. Box 36120
Doha Qatar (USA 949-547-3140)

Multimedia Assets associated with this release:
Logo: http://photos.prnewswire.com/prnh/20140213/LA65185LOGO

SOURCE HealthMed Holdings

reade more... Résuméabuiyad